相关实验视频

Updated: Jul 16, 2025

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

在肺癌早期免疫疗法新辅助试验中,理想的终点是什么?

Robert B Cameron¹, Jacobi B Hines¹, Valter Torri²

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA.

Therapeutic advances in medical oncology

|September 18, 2023

概括

在非小细胞肺癌 (NSCLC) 中确定新辅助免疫检查点抑制剂 (ICI) 试验的最佳终点至关重要. 本综述审查了医疗,外科和探索性终点,以指导未来的临床研究并改善患者的治疗结果.

科学领域:

在瘤学瘤学.
临床试验临床试验
免疫治疗是一种免疫疗法.

背景情况:

新辅助性免疫检查点抑制剂 (ICI) 在临床试验中越来越多地被研究.
完整的病理反应是某些癌症的验证代用终点,但对于非小细胞肺癌 (NSCLC) 不那么确立.
对于早期NSCLC与辅助ICI进展的最佳策略仍在争论中.

研究的目的:

审查和分析NSCLC新辅助ICI临床试验中常见报告的终点.
讨论各种终点的优点和缺点.
强调确定生存的信息和替代终点的重要性.

主要方法:

对临床试验的文献综述,调查NSCLC中新辅助ICI.
终点的分类为医疗,外科和探索.
分析每个终点类别对NSCLC试验的适用性.

主要成果:

完整的病理反应是一种潜在的代用终点,但需要在NSCLC中进一步验证.
医学终点侧重于生存和药物活性.
手术终点评估可行性和术后结果.
探索性终点包括循环瘤DNA和放射学.

结论:

选择适当的终点对于在NSCLC中高效的新辅助ICI试验设计至关重要.
需要替代终点来加速临床研究和指导治疗策略.
对各种终点的全面了解对于推进早期NSCLC治疗至关重要.

关键词:

化学免疫疗法化学免疫疗法终点终点终点终点免疫疗法免疫疗法这是一种新辅助剂.病理反应的病理反应.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...